1. Home
  2. JCSE vs INDP Comparison

JCSE vs INDP Comparison

Compare JCSE & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCSE
  • INDP
  • Stock Information
  • Founded
  • JCSE 1999
  • INDP 2000
  • Country
  • JCSE Singapore
  • INDP United States
  • Employees
  • JCSE N/A
  • INDP N/A
  • Industry
  • JCSE Miscellaneous manufacturing industries
  • INDP Biotechnology: Pharmaceutical Preparations
  • Sector
  • JCSE Consumer Discretionary
  • INDP Health Care
  • Exchange
  • JCSE Nasdaq
  • INDP Nasdaq
  • Market Cap
  • JCSE 5.9M
  • INDP 6.0M
  • IPO Year
  • JCSE 2022
  • INDP N/A
  • Fundamental
  • Price
  • JCSE $1.07
  • INDP $3.30
  • Analyst Decision
  • JCSE
  • INDP Strong Buy
  • Analyst Count
  • JCSE 0
  • INDP 2
  • Target Price
  • JCSE N/A
  • INDP $238.00
  • AVG Volume (30 Days)
  • JCSE 60.5K
  • INDP 14.7K
  • Earning Date
  • JCSE 10-29-2025
  • INDP 08-13-2025
  • Dividend Yield
  • JCSE 8.53%
  • INDP N/A
  • EPS Growth
  • JCSE N/A
  • INDP N/A
  • EPS
  • JCSE 0.00
  • INDP N/A
  • Revenue
  • JCSE $14,126,397.00
  • INDP N/A
  • Revenue This Year
  • JCSE N/A
  • INDP N/A
  • Revenue Next Year
  • JCSE N/A
  • INDP N/A
  • P/E Ratio
  • JCSE $229.49
  • INDP N/A
  • Revenue Growth
  • JCSE 6.92
  • INDP N/A
  • 52 Week Low
  • JCSE $0.86
  • INDP $3.21
  • 52 Week High
  • JCSE $2.39
  • INDP $58.24
  • Technical
  • Relative Strength Index (RSI)
  • JCSE 60.52
  • INDP 20.72
  • Support Level
  • JCSE $0.90
  • INDP $6.26
  • Resistance Level
  • JCSE $1.28
  • INDP $6.65
  • Average True Range (ATR)
  • JCSE 0.07
  • INDP 0.70
  • MACD
  • JCSE 0.02
  • INDP -0.24
  • Stochastic Oscillator
  • JCSE 45.29
  • INDP 0.06

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: